Century Therapeutics (IPSC) Enterprise Value (2022 - 2025)
Historic Enterprise Value for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to -$204.2 million.
- Century Therapeutics' Enterprise Value rose 4704.41% to -$204.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$204.2 million, marking a year-over-year increase of 4704.41%. This contributed to the annual value of -$343.4 million for FY2024, which is 1014.77% up from last year.
- Century Therapeutics' Enterprise Value amounted to -$204.2 million in Q3 2025, which was up 4704.41% from -$251.2 million recorded in Q2 2025.
- In the past 5 years, Century Therapeutics' Enterprise Value registered a high of -$156.4 million during Q2 2023, and its lowest value of -$415.3 million during Q2 2024.
- In the last 4 years, Century Therapeutics' Enterprise Value had a median value of -$315.5 million in 2022 and averaged -$297.1 million.
- As far as peak fluctuations go, Century Therapeutics' Enterprise Value skyrocketed by 5870.79% in 2023, and later crashed by 16554.15% in 2024.
- Quarter analysis of 4 years shows Century Therapeutics' Enterprise Value stood at -$315.5 million in 2022, then dropped by 21.14% to -$382.2 million in 2023, then rose by 10.15% to -$343.4 million in 2024, then soared by 40.54% to -$204.2 million in 2025.
- Its last three reported values are -$204.2 million in Q3 2025, -$251.2 million for Q2 2025, and -$293.4 million during Q1 2025.